图 1:BSF 分型 1~3 型
(Cabot Health, Bristol Stool Chart - http://cdn.intechopen.com/pdfs-wm/46082.pdf)
向上滑动阅览
参考文献:
1. 中华医学会消化病学分会胃肠动力学组. 中国肠易激综合征专家共识意见 (2015 年,上海)[J]. 中华消化杂志, 2016, 36(5):299-312.
2. ovell RM.Ford AC.Global prevalence of and risk factors for irritable bowel syndrome:a meta-analysis[J].Clin Gastroenterol Hepatol, 2012, 10(7):712-721.
3. Krarup A L , Engsbro ALØ, Fassov J , et al. Danish national guideline: Diagnosis and treatment of Irritable Bowel Syndrome[J]. danish medical journal, 2017, 7, 64(6):C5382.
4. 辛海威, 方秀才, 柯美云. 功能性便秘和便秘型肠易激综合征-我们能鉴别吗?[J]. 胃肠病学和肝病学杂志, 2013, 22(2):158-162.
5. 袁耀宗. 便秘型肠易激综合征诊疗进展专家会议纪要 [J]. 中华消化杂志, 2019, 39(3):197-198.
6. Scott A Waldman, Michael Camiller. Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders[J]. Gut, 2018, 67(8) :1543-1552.
7. 刘雪莲, 杨见权, 潘昭杰. 利那洛肽治疗便秘型肠易激综合征的 Meta 分析 [J]. 中国新药与临床杂志, 2013(08):62-67.
8. Ralph A Giannella, Elizabeth A Mann. E. Coli Heat-Stable Enterotoxin and Guanylyl Cyclase C: New Functions and Unsuspected Actions[J]. Trans Am Clin Climatol Assoc, 2003, 114:67-85.
9. Schlossmann J , Feil R , Hofmann F . Insights into cGMP signalling derived from cGMP kinase knockout mice[J]. Frontiers in Bioence, 2005, 10:1279-1289.
10. 程能能. 新型、口服肠上皮细胞鸟苷酸环化酶 C 激动剂——利那洛肽 [J]. 中国临床药学杂志, 2019, 28(4):291-295.
11. 邹多武. 利那洛肽:慢性便秘和便秘型肠易激综合征的新选择 [J]. 中华消化杂志, 2019, 39(4):286-288.
12. 杨君义. 普卡那肽: 治疗慢性特发性便秘的新型鸟苷酸环化酶 C 激动剂 [J]. 中国新药与临床杂志, 2018, 037(007):385-387.
13. Rao S , Lembo A J , Shiff S J , et al. A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation[J]. American Journal of Gastroenterology, 2012, 107(11):1714-1724.
14. Lembo A J , Schneier H A , Shiff S J , et al. Two Randomized Trials of Linaclotide for Chronic Constipation[J]. New England Journal of Medicine, 2011, 365(6):527-536.
15. Chey W D , Lembo A J , Lavins B J , et al. Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety[J]. American Journal of Gastroenterology, 2012, 107(11):1702-1712.
16. Andresen V , Miehlke S , Beck E , et al. Efficacy and tolerability of linaclotide in the treatment of?irritable bowel syndrome with constipation in a real-world setting-results from a German noninterventional study[J]. Zeitschrift für Gastroenterologie, 2018, 56(7):738-744
联系客服